MedTrace Logo

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

NCT06824844 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-02-13

No results posted yet for this study

Summary

The objective of this study is to observe the effects of 0.05% cyclosporine eye drops combined with artificial tears on patients with diabetes-associated dry eye, and to monitor changes in ocular surface characteristics and inflammatory cytokines in tears before and after treatment.

Conditions

  • Dry Eye

Interventions

DRUG

artificial tear eyedrops

The intervention group and control group were treated with artificial tear eyedrops four times a day.

DRUG

0.05% cyclosporine eyedrops

The intervention group was treated twice a day.

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Hong Qi · Peking University Third Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-02
Primary Completion
2024-03-04
Completion
2024-06-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06824844 on ClinicalTrials.gov